According to a new report, published by KBV research, The Global Arteriovenous Fistula Devices Market size is expected to reach $521.9 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period.
The Hospitals segment is leading the Global Arteriovenous Fistula Devices Market by End-use in 2022; thereby, achieving a market value of $276.2 million by 2030. Particularly in the framework of hemodialysis treatments, the hospital sector is essential in fostering the expansion of the arteriovenous fistula devices market. AVF devices are more frequently required in hospitals because of the rising demand for hemodialysis treatments and insurance reimbursement. As a consequence, the hospital sector is a major force behind the market expansion of AVF Devices.
The AVF Monitoring Devices segment is experiencing a CAGR of 7.2% during (2023 - 2030). The performance and health of the arteriovenous fistulas employed for hemodialysis are closely monitored and evaluated with the help of AVF monitoring equipment. Effective monitoring tools are also essential to ensure optimal operation and the early identification of issues as the number of people with AVFs rises. To fulfill these expectations, a number of cutting-edge products have been released in the AVF monitoring device category. Over the course of the forecast, this aspect is predicted to fuel segment expansion.
The North America region dominated the Global Arteriovenous Fistula Devices Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $204.9 million by 2030. The Europe region is estimated to grow at a CAGR of 6.7% during (2023 - 2030). Additionally, The Asia Pacific region would exhibit a CAGR of 8% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/arteriovenous-fistula-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Becton, Dickinson and Company, Teleflex, Inc., Fresenius Medical Care AG & Co. KGaA. (Fresenius SE & Co. KGaA), B. Braun Melsungen AG, Poly Medicure Ltd., Asahi Kasei Corporation, Laminate Medical Technologies Ltd., Cook Medical, Inc. (Cook Group), and Boston Scientific Corporation.
By End-use
By Type
By Geography
Companies Profiled
Unique Offerings 
